HKD 0.5
(6.38%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 140.78 Million HKD | -16.43% |
2022 | 106.23 Million HKD | 26.53% |
2021 | 122.35 Million HKD | 92.19% |
2020 | 46.12 Million HKD | -56.54% |
2019 | 150.61 Million HKD | 0.04% |
2018 | 153.83 Million HKD | -2.27% |
2017 | 150.59 Million HKD | 99.12% |
2016 | 79.91 Million HKD | -23.86% |
2015 | 103.93 Million HKD | 4.57% |
2014 | 100.95 Million HKD | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q2 | 62.36 Million HKD | 0.0% |
2023 Q1 | 30.92 Million HKD | -52.59% |
2023 Q2 | 61.84 Million HKD | 100.0% |
2023 Q3 | 32.92 Million HKD | -46.76% |
2023 Q4 | 68.4 Million HKD | 107.75% |
2023 FY | - HKD | -16.43% |
2022 Q1 | 30.09 Million HKD | -46.08% |
2022 FY | - HKD | 26.53% |
2022 Q4 | 65.22 Million HKD | 49.63% |
2022 Q3 | 43.58 Million HKD | -27.59% |
2022 Q2 | 60.19 Million HKD | 100.0% |
2021 FY | - HKD | 92.19% |
2021 Q1 | 31.77 Million HKD | 305.62% |
2021 Q4 | 55.81 Million HKD | 105.48% |
2021 Q2 | 65.32 Million HKD | 105.59% |
2021 Q3 | 27.16 Million HKD | -58.42% |
2020 Q2 | 47.31 Million HKD | 109.34% |
2020 Q4 | 7.83 Million HKD | 143.82% |
2020 FY | - HKD | -56.54% |
2020 Q1 | 22.6 Million HKD | -69.06% |
2020 Q3 | 3.21 Million HKD | -93.21% |
2019 Q2 | 71.96 Million HKD | 101.2% |
2019 Q1 | 35.76 Million HKD | -48.96% |
2019 FY | - HKD | 0.04% |
2019 Q4 | 73.04 Million HKD | 112.03% |
2019 Q3 | 34.45 Million HKD | -52.13% |
2018 FY | - HKD | -2.27% |
2018 Q4 | 70.07 Million HKD | 100.0% |
2018 Q3 | 35.03 Million HKD | -5.28% |
2018 Q2 | 36.99 Million HKD | 0.0% |
2018 Q1 | 36.99 Million HKD | 3.34% |
2017 Q1 | 32.44 Million HKD | -8.54% |
2017 FY | - HKD | 99.12% |
2017 Q4 | 35.79 Million HKD | 0.0% |
2017 Q3 | 35.79 Million HKD | 10.33% |
2017 Q2 | 32.44 Million HKD | 0.0% |
2016 FY | - HKD | -23.86% |
2016 Q1 | 30.03 Million HKD | 60.54% |
2016 Q2 | 30.03 Million HKD | 0.0% |
2016 Q4 | 35.47 Million HKD | 0.0% |
2016 Q3 | 35.47 Million HKD | 18.1% |
2015 Q4 | 18.7 Million HKD | -24.79% |
2015 Q3 | 24.87 Million HKD | 0.0% |
2015 Q2 | 24.87 Million HKD | 0.0% |
2015 Q1 | 24.87 Million HKD | 0.0% |
2015 FY | - HKD | 4.57% |
2014 FY | - HKD | 0.0% |
2014 Q4 | 24.87 Million HKD | 1.52% |
2014 Q3 | 24.5 Million HKD | 0.0% |
2014 Q2 | 24.5 Million HKD | 0.0% |
2014 Q1 | 24.5 Million HKD | 0.0% |
2013 Q4 | 24.5 Million HKD | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Natural Beauty Bio-Technology Limited | 22.91 Million HKD | -514.447% |
Innovative Pharmaceutical Biotech Limited | 317.74 Million HKD | 55.693% |
China Overseas Nuoxin International Holdings Limited | 2.02 Million HKD | -6838.492% |
Prosperous Future Holdings Limited | -19.68 Million HKD | 815.138% |
Huasheng International Holding Limited | 19.67 Million HKD | -615.428% |
Fourace Industries Group Holdings Limited | 61.52 Million HKD | -128.821% |
EC Healthcare | 737.83 Million HKD | 80.919% |
Ming Fai International Holdings Limited | 211.83 Million HKD | 33.541% |
Blue Moon Group Holdings Limited | 656.37 Million HKD | 78.552% |
SuperRobotics Holdings Limited | -7.39 Million HKD | 2002.717% |
Takbo Group Holdings Limited | 25.8 Million HKD | -445.582% |
Hyfusin Group Holdings Limited | 154.18 Million HKD | 8.694% |